This inventor holds 2 USPTO granted patents and 6 published patent applications. Top assignee: Quark Biosciences Taiwan, Inc.. Active years: 2019-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2020
Title: Shih-Ting Kang: Innovator in miRNA Detection Technology
Introduction
Shih-Ting Kang is a notable inventor based in Hsinchu County, Taiwan. He has made significant contributions to the field of molecular biology, particularly in the area of miRNA detection. With a total of 2 patents, his work has advanced the methodologies used in genetic research and diagnostics.
Latest Patents
Kang's latest patents focus on a nucleotide sequence, a universal reverse primer, and a universal RT primer. These innovations are crucial for the synthesis of cDNA from miRNA samples and for amplifying cDNA molecules in quantitative PCR (qPCR) detection. The universal reverse primer sequence, along with the nucleotide sequence and design rules, plays a vital role in designing primers for effective qPCR quantitative detection.
Career Highlights
Shih-Ting Kang is currently employed at Quark Biosciences Taiwan, Inc. His work at this company has allowed him to collaborate with other experts in the field, enhancing the impact of his inventions.
Collaborations
One of his notable coworkers is Wei-Ming Chen, who contributes to the innovative environment at Quark Biosciences Taiwan, Inc.
Conclusion
Shih-Ting Kang's contributions to miRNA detection technology exemplify the importance of innovation in molecular biology. His patents and work at Quark Biosciences Taiwan, Inc. continue to influence the field significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile